Dermatologists play a key role in detecting patients at risk for complications from tattooing.
The FDA has approved Upneeq™ (oxymetazoline hydrochloride ophthalmic solution; Osmotica) for the treatment of acquired blepharoptosis in adults.
Results from both studies showed treatment with Qwo was associated with greater reductions in cellulite severity compared with placebo as measured by CR-PCSS and PR-PCSS scales at day 71.
Americans have a positive attitude toward plastic surgery in the COVID-19 period, and recommendations have been issued for resuming elective procedures.
The FDA has approved Restylane® Kysse (Galderma) for lip augmentation and the correction of upper perioral rhytids in adults aged >21 years.
A cream with Tranexamic acid proves far more active than cream without Tranexamic in the treatment of inflammatory hypervascular and telangiectatic melasma.
How much of an influence does the consumption of polyphenols have on the suppression of pigmented spots? A considerable influence, a study finds.
A new device allows plastic surgeons to perform three-dimensional nipple tattoos as part of breast reconstruction.
A new method of face-lift surgery eliminates visible scars for bald men undergoing the procedure.
The use of the drug delivery system combined with topical rapamycin improves the results of pulsed dye laser (PDL) treatment for port wine stains and can reduce the total number of necessary PDL sessions, with no remarkable adverse events.